BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jain S, Jacobson KA. Purinergic signaling in diabetes and metabolism. Biochem Pharmacol 2021;187:114393. [PMID: 33359363 DOI: 10.1016/j.bcp.2020.114393] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Barella LF, Jain S, Pydi SP. G protein-coupled receptors: Role in metabolic disorders. Front Endocrinol 2022;13:984253. [DOI: 10.3389/fendo.2022.984253] [Reference Citation Analysis]
2 Ferrari D, Rubini M, Burns JS. The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2. Front Immunol 2022;13:904419. [DOI: 10.3389/fimmu.2022.904419] [Reference Citation Analysis]
3 García-Villalba J, Hurtado-Navarro L, Peñín-Franch A, Molina-López C, Martínez-Alarcón L, Angosto-Bazarra D, Baroja-Mazo A, Pelegrin P. Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity. Front Immunol 2022;13:894470. [PMID: 35663992 DOI: 10.3389/fimmu.2022.894470] [Reference Citation Analysis]
4 Han XX, Holst JJ, Galbo H. Studies in Rats of Combined Muscle and Liver Perfusion and of Muscle Extract Indicate That Contractions Release a Muscle Hormone Directly Enhancing Hepatic Glycogenolysis. JPM 2022;12:837. [DOI: 10.3390/jpm12050837] [Reference Citation Analysis]
5 Chiang CH, Cheng CY, Lien YT, Huang KC, Lin WW. P2X7 Activation Enhances Lipid Accumulation During Adipocytes Differentiation Through Suppressing the Expression of Sirtuin-3, Sirtuin-5, and Browning Genes. Front Pharmacol 2022;13:852858. [PMID: 35462937 DOI: 10.3389/fphar.2022.852858] [Reference Citation Analysis]
6 Jain S, Jacobson KA. Adipocyte purinergic receptors activated by uracil nucleotides as obesity and type 2 diabetes targets. Current Opinion in Pharmacology 2022;63:102190. [DOI: 10.1016/j.coph.2022.102190] [Reference Citation Analysis]
7 Le Y, Lu D, Xue M. Purinergic signaling in thyroid disease. Purinergic Signal 2022. [PMID: 35347568 DOI: 10.1007/s11302-022-09858-2] [Reference Citation Analysis]
8 Garcia-jacobo RE, Bergamin LS, Vultaggio-poma V, Thorstenberg ML, Tarantini M, García-hernández MH, Di Virgilio F. The Purinergic Landscape of Type 2 Diabetes Mellitus. Molecules 2022;27:1838. [DOI: 10.3390/molecules27061838] [Reference Citation Analysis]
9 Bianca Maria Platania C, Drago F, Bucolo C. The P2X7 receptor as a new pharmacological target for retinal diseases. Biochemical Pharmacology 2022. [DOI: 10.1016/j.bcp.2022.114942] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Val C, Rodríguez-garcía C, Prieto-díaz R, Crespo A, Azuaje J, Carbajales C, Majellaro M, Díaz-holguín A, Brea JM, Loza MI, Gioé-gallo C, Contino M, Stefanachi A, García-mera X, Estévez JC, Gutiérrez-de-terán H, Sotelo E. Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A 1 Antagonists. J Med Chem . [DOI: 10.1021/acs.jmedchem.1c01636] [Reference Citation Analysis]
11 Li X, Gao J, Tao J. Purinergic Signaling in the Regulation of Gout Flare and Resolution. Front Immunol 2021;12:785425. [PMID: 34925366 DOI: 10.3389/fimmu.2021.785425] [Reference Citation Analysis]
12 Zuccarini M, Lambertucci C, Carluccio M, Giuliani P, Ronci M, Spinaci A, Volpini R, Ciccarelli R, Di Iorio P. Multipotent Stromal Cells from Subcutaneous Adipose Tissue of Normal Weight and Obese Subjects: Modulation of Their Adipogenic Differentiation by Adenosine A1 Receptor Ligands. Cells 2021;10:3560. [PMID: 34944069 DOI: 10.3390/cells10123560] [Reference Citation Analysis]
13 Szrejder M, Rogacka D, Piwkowska A. Purinergic P2 receptors: Involvement and therapeutic implications in diabetes-related glomerular injury. Arch Biochem Biophys 2021;714:109078. [PMID: 34742673 DOI: 10.1016/j.abb.2021.109078] [Reference Citation Analysis]
14 Zhao Y, Chen X, He C, Gao G, Chen Z, Du J. Discovery of bilirubin as novel P2X7R antagonist with anti-tumor activity. Bioorg Med Chem Lett 2021;51:128361. [PMID: 34543755 DOI: 10.1016/j.bmcl.2021.128361] [Reference Citation Analysis]
15 Sagrillo-Fagundes L, Casagrande Paim T, Pretto L, Bertaco I, Zanatelli C, Vaillancourt C, Wink MR. The implications of the purinergic signaling throughout pregnancy. J Cell Physiol 2021. [PMID: 34596240 DOI: 10.1002/jcp.30594] [Reference Citation Analysis]
16 Jain S, Jacobson KA. Purinergic Signaling in Liver Pathophysiology. Front Endocrinol (Lausanne) 2021;12:718429. [PMID: 34456873 DOI: 10.3389/fendo.2021.718429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Jain S, Barella LF, Wess J, Reitman ML, Jacobson KA. Adenosine A1 receptor is dispensable for hepatocyte glucose metabolism and insulin sensitivity. Biochem Pharmacol 2021;192:114739. [PMID: 34418353 DOI: 10.1016/j.bcp.2021.114739] [Reference Citation Analysis]
18 Jain S, Pydi SP, Jung YH, Scortichini M, Kesner EL, Karcz TP, Cook DN, Gavrilova O, Wess J, Jacobson KA. Adipocyte P2Y14 receptors play a key role in regulating whole-body glucose and lipid homeostasis. JCI Insight 2021;6:146577. [PMID: 34027896 DOI: 10.1172/jci.insight.146577] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Caruso V, Zuccarini M, Di Iorio P, Muhammad I, Ronci M. Metabolic Changes Induced by Purinergic Signaling: Role in Food Intake. Front Pharmacol 2021;12:655989. [PMID: 33995077 DOI: 10.3389/fphar.2021.655989] [Reference Citation Analysis]